SILVERSUN TECHNOLOGIES INC (SSNT) Fundamental Analysis & Valuation

NASDAQ:SSNT • US82846H2076

Current stock price

16.31 USD
-3.3 (-16.83%)
At close:
16.5 USD
+0.19 (+1.16%)
After Hours:

This SSNT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. SSNT Profitability Analysis

1.1 Basic Checks

  • In the past year SSNT has reported negative net income.
  • In the past year SSNT had a positive cash flow from operations.
  • In multiple years SSNT reported negative net income over the last 5 years.
  • Of the past 5 years SSNT 4 years had a positive operating cash flow.
SSNT Yearly Net Income VS EBIT VS OCF VS FCFSSNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M

1.2 Ratios

  • SSNT has a Return On Assets (-5.81%) which is comparable to the rest of the industry.
  • SSNT has a Return On Equity of -15.94%. This is comparable to the rest of the industry: SSNT outperforms 49.28% of its industry peers.
  • With an excellent Return On Invested Capital value of 13.65%, SSNT belongs to the best of the industry, outperforming 92.03% of the companies in the same industry.
Industry RankSector Rank
ROA -5.81%
ROE -15.94%
ROIC 13.65%
ROA(3y)-2.43%
ROA(5y)5.94%
ROE(3y)-6.24%
ROE(5y)12.03%
ROIC(3y)N/A
ROIC(5y)N/A
SSNT Yearly ROA, ROE, ROICSSNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

1.3 Margins

  • SSNT's Operating Margin of 2.75% is fine compared to the rest of the industry. SSNT outperforms 68.84% of its industry peers.
  • In the last couple of years the Operating Margin of SSNT has grown nicely.
  • SSNT has a worse Gross Margin (39.26%) than 77.90% of its industry peers.
  • In the last couple of years the Gross Margin of SSNT has remained more or less at the same level.
Industry RankSector Rank
OM 2.75%
PM (TTM) N/A
GM 39.26%
OM growth 3Y79.19%
OM growth 5Y25.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5Y-0.8%
SSNT Yearly Profit, Operating, Gross MarginsSSNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. SSNT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SSNT is creating some value.
  • SSNT has more shares outstanding than it did 1 year ago.
  • SSNT has a worse debt/assets ratio than last year.
SSNT Yearly Shares OutstandingSSNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
SSNT Yearly Total Debt VS Total AssetsSSNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

  • An Altman-Z score of 3.32 indicates that SSNT is not in any danger for bankruptcy at the moment.
  • SSNT has a Altman-Z score (3.32) which is in line with its industry peers.
  • SSNT has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
  • SSNT's Debt to FCF ratio of 1.25 is fine compared to the rest of the industry. SSNT outperforms 71.74% of its industry peers.
  • A Debt/Equity ratio of 0.14 indicates that SSNT is not too dependend on debt financing.
  • The Debt to Equity ratio of SSNT (0.14) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.25
Altman-Z 3.32
ROIC/WACC1.37
WACC10%
SSNT Yearly LT Debt VS Equity VS FCFSSNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M 8M

2.3 Liquidity

  • SSNT has a Current Ratio of 1.05. This is a normal value and indicates that SSNT is financially healthy and should not expect problems in meeting its short term obligations.
  • SSNT has a worse Current ratio (1.05) than 74.28% of its industry peers.
  • SSNT has a Quick Ratio of 1.05. This is a normal value and indicates that SSNT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.05, SSNT is doing worse than 73.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
SSNT Yearly Current Assets VS Current LiabilitesSSNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. SSNT Growth Analysis

3.1 Past

  • SSNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -66220640690479628288.00%.
  • Looking at the last year, SSNT shows a quite strong growth in Revenue. The Revenue has grown by 18.53% in the last year.
  • The Revenue has been growing slightly by 5.86% on average over the past years.
EPS 1Y (TTM)-66220640690479630000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%315.64%
Revenue 1Y (TTM)18.53%
Revenue growth 3Y9.77%
Revenue growth 5Y5.86%
Sales Q2Q%9.98%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSNT Yearly Revenue VS EstimatesSSNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
SSNT Yearly EPS VS EstimatesSSNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 0.05 0.1 0.15

More info and screens

Find the best growth stocksShow best growing peers

2

4. SSNT Valuation Analysis

4.1 Price/Earnings Ratio

  • SSNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SSNT Price Earnings VS Forward Price EarningsSSNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SSNT indicates a rather cheap valuation: SSNT is cheaper than 98.55% of the companies listed in the same industry.
  • SSNT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SSNT is cheaper than 97.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7
EV/EBITDA 2.53
SSNT Per share dataSSNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SSNT Dividend Analysis

5.1 Amount

  • SSNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SSNT Fundamentals: All Metrics, Ratios and Statistics

SILVERSUN TECHNOLOGIES INC

NASDAQ:SSNT (6/5/2024, 8:18:16 PM)

After market: 16.5 +0.19 (+1.16%)

16.31

-3.3 (-16.83%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07
Earnings (Next)08-06
Inst Owners0.07%
Inst Owner Change0%
Ins Owners78.89%
Ins Owner Change0%
Market Cap10.84M
Revenue(TTM)55.83M
Net Income(TTM)-1.21M
Analysts82.5
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.2
Dividend Growth(5Y)N/A
DP-86.68%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF 7
P/OCF 6.27
P/B 1.42
P/tB 6.15
EV/EBITDA 2.53
EPS(TTM)-2.3
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.33
FCFY14.28%
OCF(TTM)2.6
OCFY15.96%
SpS84.02
BVpS11.45
TBVpS2.65
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.81%
ROE -15.94%
ROCE 17.28%
ROIC 13.65%
ROICexc 46.51%
ROICexgc N/A
OM 2.75%
PM (TTM) N/A
GM 39.26%
FCFM 2.77%
ROA(3y)-2.43%
ROA(5y)5.94%
ROE(3y)-6.24%
ROE(5y)12.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y90.48%
ROICexc growth 5Y39.11%
OM growth 3Y79.19%
OM growth 5Y25.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5Y-0.8%
F-Score3
Asset Turnover2.68
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.25
Debt/EBITDA 0.42
Cap/Depr 17.67%
Cap/Sales 0.33%
Interest Coverage 53.51
Cash Conversion 67.48%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 3.32
F-Score3
WACC10%
ROIC/WACC1.37
Cap/Depr(3y)14.01%
Cap/Depr(5y)16%
Cap/Sales(3y)0.31%
Cap/Sales(5y)0.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66220640690479630000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%315.64%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.53%
Revenue growth 3Y9.77%
Revenue growth 5Y5.86%
Sales Q2Q%9.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y534.44%
EBIT growth 3Y96.7%
EBIT growth 5Y32.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y166.87%
FCF growth 3Y-34%
FCF growth 5Y-2.67%
OCF growth 1Y140.18%
OCF growth 3Y-30.38%
OCF growth 5Y-14.66%

SILVERSUN TECHNOLOGIES INC / SSNT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SILVERSUN TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to SSNT.


Can you provide the valuation status for SILVERSUN TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 1 / 10 to SILVERSUN TECHNOLOGIES INC (SSNT). This can be considered as Overvalued.


What is the profitability of SSNT stock?

SILVERSUN TECHNOLOGIES INC (SSNT) has a profitability rating of 4 / 10.


Is the dividend of SILVERSUN TECHNOLOGIES INC sustainable?

The dividend rating of SILVERSUN TECHNOLOGIES INC (SSNT) is 0 / 10 and the dividend payout ratio is -86.68%.